V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20164501 | 20063229 | 1.73 | 90.8 | Neo-adjuvant (N) | 2018-03-12 | 2018-03-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100802958 |
| 20164502 | 20063230 | 1.78 | 58.2 | Neo-adjuvant (N) | 2018-06-22 | 2018-07-08 | ECX | 02 | N | ECX | 100060242 |
| 20164513 | 20063231 | 1.5 | 95.6 | Neo-adjuvant (N) | 2016-05-18 | 2016-05-26 | ECX | N | N | ECX | 100634356 |
| 20164514 | 20063232 | 1.83 | 64.9 | null | 2016-09-28 | 2016-10-21 | Gemcitabine + Capecitabine | N | N | ECX | 100128386 |
| 20164515 | 20063233 | 1.88 | 92 | Palliative (P) | 2017-11-18 | 2017-11-30 | ECX | 02 | N | ECX | 100660538 |
| 20164517 | 20063234 | 1.7 | 64.5 | null | 2017-05-06 | 2017-05-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100801350 |
| 20164519 | 20063235 | 1.65 | 94 | Palliative (P) | null | 2019-01-27 | ECX | null | N | ECX | 100965741 |
| 20164522 | 20063236 | 1.58 | 75 | Adjuvant (A) | 2016-07-05 | 2016-07-25 | ECX | N | N | ECX | 101832755 |
| 20164523 | 20063237 | 1.84 | 61.2 | Palliative (P) | null | 2018-01-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100614661 |
| 20164526 | 20063238 | 1.8 | 80 | Palliative (P) | 2017-08-12 | 2017-08-12 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100000893 |
| 20164528 | 20063239 | 1.78 | 48.9 | Neo-adjuvant (N) | 2018-05-17 | 2018-05-17 | ECX | 02 | N | ECX | 100717179 |
| 20164535 | 20063240 | 1.58 | 68.65 | Palliative (P) | 2016-09-05 | 2016-09-23 | ECX | N | N | ECX | 101153892 |
| 20164537 | 20063241 | 1.65 | 63.4 | Curative (C) | 2017-06-12 | 2017-06-18 | ECX | 02 | N | ECX | 101124953 |
| 20164540 | 20063242 | 1.61 | 65.7 | Neo-adjuvant (N) | 2018-11-25 | 2018-12-02 | ECX | N | N | ECX | 101358445 |
| 20164542 | 20063243 | 1.6 | 54 | Neo-adjuvant (N) | 2016-12-15 | 2016-12-29 | ECX | N | N | ECX | 100081256 |
| 20164548 | 20063244 | 1.74 | 55.8 | Neo-adjuvant (N) | 2017-04-06 | 2017-05-01 | ECX | N | N | ECX | 101222812 |
| 20164559 | 20063245 | 1.66 | 87.8 | Adjuvant (A) | 2017-06-23 | 2017-06-26 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100132992 |
| 20164560 | 20063246 | 1.74 | 90.8 | null | 2019-06-05 | 2019-06-26 | Gemcitabine + Capecitabine | N | N | ECX | 100768957 |
| 20164562 | 20063247 | 1.85 | 119 | Neo-adjuvant (N) | 2019-08-23 | 2019-08-25 | ECX | N | N | ECX | 101191054 |
| 20164566 | 20063248 | 1.53 | 102.2 | Neo-adjuvant (N) | 2018-05-12 | 2018-05-26 | ECX | 02 | N | ECX | 100926389 |
| 20164568 | 20063249 | 1.71 | 60.7 | Palliative (P) | 2018-10-16 | 2018-10-29 | ECX | N | Y | ECX | 100331240 |
| 20164569 | 20063250 | 1.78 | 51 | Neo-adjuvant (N) | 2017-06-14 | 2017-06-14 | ECX | 02 | N | ECX | 101666136 |
| 20164571 | 20063251 | 1.77 | 71.4 | Adjuvant (A) | 2019-03-17 | 2019-03-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101311872 |
| 20164582 | 20063252 | 1.57 | 69.7 | Neo-adjuvant (N) | 2019-02-01 | 2019-02-19 | ECX | N | N | ECX | 100024725 |
| 20164583 | 20063253 | 1.6 | 58.5 | Neo-adjuvant (N) | 2017-05-11 | 2017-05-26 | ECX | N | N | ECX | 101015432 |
| 20164590 | 20063254 | 1.62 | 68 | Neo-adjuvant (N) | 2019-04-08 | 2019-04-22 | ECX | 2 | N | ECX | 100524888 |
| 20164593 | 20063255 | 1.7 | 67.8 | Palliative (P) | 2018-01-22 | 2018-02-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100632938 |
| 20164613 | 20063256 | 1.65 | 66.6 | Palliative (P) | 2016-09-09 | 2016-09-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101123650 |
| 20164614 | 20063257 | 1.61 | 100.6 | Palliative (P) | 2020-01-01 | 2020-01-01 | ECX | N | null | ECX | 101233134 |
| 20164620 | 20063258 | 1.84 | 77.5 | Palliative (P) | 2017-11-26 | 2017-12-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101061486 |
| 20164626 | 20063259 | 1.8 | 78.4 | Palliative (P) | 2016-10-31 | 2016-11-13 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101711753 |
| 20164627 | 20063260 | 1.67 | 77 | null | 2019-12-18 | 2020-01-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100980565 |
| 20164628 | 20063261 | 1.57 | 84 | null | 2017-04-07 | 2017-05-02 | ECX | N | N | ECX | 100217121 |
| 20164631 | 20063262 | 1.9 | 44 | Palliative (P) | 2017-06-11 | 2017-07-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101558141 |
| 20164633 | 20063263 | 1.79 | 95 | 02 | 2017-10-27 | 2017-10-31 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100129644 |
| 20164639 | 20063264 | null | null | Curative (C) | 2016-08-30 | 2016-08-30 | ECX | 2 | N | ECX | 100935638 |
| 20164650 | 20063265 | 1.5 | 102.2 | Neo-adjuvant (N) | 2018-04-22 | 2018-05-01 | ECX | N | N | ECX | 100396592 |
| 20164653 | 20063266 | 1.75 | 90.3 | Palliative (P) | 2019-10-18 | 2019-10-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100041448 |
| 20164671 | 20063267 | 1.85 | 95.8 | Adjuvant (A) | 2017-06-10 | 2017-06-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101678705 |
| 20164673 | 20063268 | 1.66 | 53 | Neo-adjuvant (N) | 2019-05-17 | 2019-05-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101337081 |
| 20164686 | 20063269 | 1.81 | 65.8 | Palliative (P) | 2018-02-01 | 2018-02-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100472883 |
| 20164689 | 20063270 | 1.66 | 78.7 | Palliative (P) | 2018-02-21 | 2018-02-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100125188 |
| 20164690 | 20063271 | 1.84 | 76.2 | Palliative (P) | 2016-09-04 | 2016-09-19 | ECX | N | N | ECX | 101090859 |
| 20164705 | 20063272 | 1.63 | 93 | Neo-adjuvant (N) | 2019-09-12 | 2019-09-16 | ECX | 2 | N | ECX | 100965281 |
| 20164711 | 20063273 | 1.53 | 47.7 | Adjuvant (A) | 2019-11-26 | 2019-12-08 | ECX | N | N | ECX | 100887224 |
| 20164714 | 20063274 | 1.7 | 79 | null | 2018-01-20 | 2018-02-09 | Gemcitabine + Capecitabine | 02 | Y | ECX | 101261374 |
| 20164715 | 20063275 | 1.74 | 62 | null | 2018-11-26 | 2018-11-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101286614 |
| 20164716 | 20063276 | 1.63 | 76.5 | Curative (C) | 2018-11-20 | 2018-11-24 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101763743 |
| 20164719 | 20063277 | 1.56 | 97.8 | Neo-adjuvant (N) | 2016-09-12 | 2016-09-24 | ECX | N | null | ECX | 100180277 |
| 20164720 | 20063278 | null | 50 | Curative (C) | 2018-08-08 | 2018-08-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100446547 |